Open tender · Germany · Contract notice
Abschluss eines nicht exklusiven Rabattvertrages nach § 130a Abs. 8 SGB V zu Arzneimitteln mit dem Wirkstoff Interferon beta-1b (ATC-Code L03AB08).
AOK Niedersachsen. Die Gesundheitskasse.
AOK Niedersachsen. Die Gesundheitskasse. in Germany is inviting bids for “Abschluss eines nicht exklusiven Rabattvertrages nach § 130a Abs. 8 SGB V zu Arzneimitteln mit dem Wirkstoff Interferon beta-1b (ATC-Code L03AB08)”. Bids close on 27 March 2027.
The work
Conclusion of a non-exclusive discount contract for the active substance Interferon beta-1b (ATC-Code L03AB08) with AOK Niedersachsen from 01.06.2025 to 31.05.2027.
- Must be a pharmaceutical entrepreneur as per § 4 Abs. 18 AMG
- Must have a seat in the EU/EEA as per § 9 Abs. 2 Satz 1 AMG
- No individual negotiations, standard conditions apply
Key facts
- Contract period
- Up to 24 months from the first of a month, ending no later than 31.05.2027.
What it takes to qualify
Worth a closer look
- The text is a public notice for a contract, not a standard tender. It states it is not a public contract under Directive 2014/24/EU.
- The submission mode is not specified, only a physical address is mentioned.
Policy conditions
No reservation, preference or local-content restriction.
Documents to submit
- Contractual documents and conditionsRequested under I.1) contact address
- Proof of being a pharmaceutical entrepreneurAs per § 4 Abs. 18 AMG
- Proof of having a seat in the EU/EEAAs per § 9 Abs. 2 Satz 1 AMG